Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-20-059427

SVP, Clinical Dev, Drug Safety acquired 7,082 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kouchakji Elias · SVP, Clinical Dev, Drug Safety

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-11-17 Exercise or conversion : show line 1 in the form +7,082 $14.58 $103,220 134,495 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-11-17 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −7,082 $14.58 2024-03-19 7,082 0 D
Loading xslF345X03/doc4.xml…